Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2215339 | 0.88 | ALDH1A1 (0.61) | ALDH1A1TSHRTHRBTDP1ELANE | |
| SCHEMBL27687654 | 0.83 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBTDP1ELANE | |
| SCHEMBL29011420 | 0.80 | ALDH1A1 (0.52) | ALDH1A1TSHRTHRBTDP1ELANE | |
| SCHEMBL28888840 | 0.80 | ALDH1A1 (0.52) | ALDH1A1TSHRTHRBTDP1ELANE | |
| SCHEMBL3671288 | 0.80 | ALDH1A1 (0.52) | ALDH1A1TSHRTHRBTDP1ELANE | |
| SCHEMBL177817 | 0.77 | ALDH1A1 (0.55) | ALDH1A1TSHRTHRBTDP1ELANE | |
| Methacrylic Acid SCHEMBL15452850 | 0.76 | ALDH1A1 (0.48) | ALDH1A1TSHRTHRBTDP1ELANE | |
| Methacrylic Acid SCHEMBL15452844 | 0.76 | ALDH1A1 (0.48) | ALDH1A1TSHRTHRBTDP1ELANE | |
| Methacrylic Acid SCHEMBL15452900 | 0.76 | ALDH1A1 (0.48) | ALDH1A1TSHRTHRBTDP1ELANE | |
| Methacrylic Acid SCHEMBL15452951 | 0.76 | ALDH1A1 (0.48) | ALDH1A1TSHRTHRBTDP1ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4501303-A2 | INORGANIC DENTAL FILLERS INCLUDING A SILANE TREATED SURFACE | Solventum Intellectual Properties Company (US) | 2025-02-05 | — | — | EP | disclosed |
| US-20200315924-A1 | INORGANIC DENTAL FILLERS INCLUDING A SILANE TREATED SURFACE | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2020-10-08 | — | — | US | disclosed |
| CN-110431170-A | Method for adhering cured silicone to low energy plastics and composite materials prepared by the method | DOW SILICONES CORP | 2019-11-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200315924-A1 | INORGANIC DENTAL FILLERS INCLUDING A SILANE TREATED SURFACE | MSR1, H1-2, H1-3 | ALDH1A1 2155/4885TSHR 238/4885THRB 2072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.